Goldman Sachs Puts Its President on the Board: What Changes Legally

Goldman Sachs named its president and chief operating officer John Waldron to its board of directors, Banking Dive reported on Feb. 27, 2025.

David Solomon is chairman and chief executive officer, according to Goldman Sachs. Waldron is president. The hierarchy is clear. One chair-CEO. One president-COO, the No. 2 who runs day-to-day operations.

A board seat changes the legal role. A director votes on board decisions. A director owes fiduciary duties, meaning a legal duty to act in the company's best interest. A director also sits with independent directors, board members who are not executives, in executive sessions and committee work, not only in operating reviews.

The Wall Street Journal published an article titled "Goldman Sachs Is at War With Itself" on June 13, 2023. That reporting identified Waldron as Goldman's president and Solomon's second in command. It described Waldron as "considered a top contender."

The key distinction on timing is this. The 2025 appointment is the official record of who is on the board. The 2023 description is background. It does not change the current facts.

The broader context here is how large banks keep succession options open without making a promise. A sitting president-COO on the board lets independent directors watch him over many quarters. They can judge performance under stress, discipline on capital allocation, which is how the bank spends and risks its money, and communication with regulators and large clients. No search mandate is required. No timetable is disclosed.

In my view, the setup also tightens the information loop at the top. A president-COO with a board seat gets formal access to board papers, minutes and debate. That reduces the knowledge gap between the chair-CEO and the No. 2. Continuity improves. The trade-off is familiar. The No. 2 now sits on both sides of the management-board line. For practitioners, the test is independence in practice: how often and how frankly the board meets without managers present, who sits on committees, and whether the board still measures the top job against outside candidates even with an internal candidate in the room.

Looking at what this means for governance risk, the appointment narrows but does not settle the duality question of one person holding both chair and CEO. A combined chair-CEO plus a president-COO on the board puts operating and boardroom influence with two officers. Continuity risk falls. Concentration risk stays. Large clients and counterparties often read a board-level No. 2 as smoother if a handover is needed. Proxy advisers and supervisors often ask a different question: can the board still run an open process, including outside candidates, if conditions change.

From a governance view for a bank holding company, the test is procedural. Charters, succession plans, evaluation criteria and recusal rules, which set when someone steps aside from a decision, matter more than titles.

Put simply, a board seat does not name a successor. It gives the board longer exposure, better information and fewer excuses if a transition becomes necessary. That is the narrow but real content of the February 2025 disclosure when read alongside the earlier Journal reporting.